Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Apr 8;6(4):e413.
doi: 10.1038/bcj.2016.18.

A Genomic Analysis of Philadelphia Chromosome-Negative AML Arising in Patients With CML

Affiliations
Free PMC article
Case Reports

A Genomic Analysis of Philadelphia Chromosome-Negative AML Arising in Patients With CML

K Krysiak et al. Blood Cancer J. .
Free PMC article

Figures

Figure 1
Figure 1
Exome variants in CML samples versus AML samples arising in the same patient. Genomic DNA was isolated from cryopreserved AML bone marrow aspirates, CML bone marrow fixed core and a skin punch biopsy (control) for sequencing. (a) Exome (Y axis) versus Ampliseq (X axis) allele frequencies for case 2 variants that validated by Ampliseq (N=29) are plotted for both AML (left panel) and CML (right panel) samples. Pearson's correlation coefficient is shown. (b) Filtered exome variants plotted by allele frequency in CML sample (Y axis) versus frequency in AML sample (X axis) for case 1 (left panel, N=52) and case 2 (right panel, N=33). (c) Sanger sequencing traces showing region of EEF1A1 5′ UTR from case 1. CML and AML samples show GGGC deletion in one allele (left and middle panels, arrows) whereas T lymphocytes sorted from a remission sample shows wild-type sequence (right panel, red bracket).

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 2004; 19: 460–463. - PubMed
    1. Bumm T. Emergence of clonal cytogenetic abnormalities in Ph-cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. Blood 2002; 101: 1941–1949. - PubMed
    1. Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C et al. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia 2004; 18: 1340–1346. - PubMed
    1. Deininger MWN, Cortes J, Paquette R, Park B, Hochhaus A, Baccarani M et al. The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells. Cancer 2007; 110: 1509–1519. - PubMed
    1. Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 2006; 108: 2811–2813. - PubMed

MeSH terms

Feedback